Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SAI Life Sciences Ltd. ( (IN:SAILIFE) ) has shared an announcement.
Sai Life Sciences Ltd. has submitted a disclosure to the National Stock Exchange of India and BSE Limited under Regulation 31(4) of SEBI’s Substantial Acquisition of Shares and Takeovers Regulations, 2011. This disclosure pertains to information received from Mr. Krishnam Raju Kanumuri, a promoter of the company, indicating compliance with regulatory requirements and maintaining transparency with stakeholders.
More about SAI Life Sciences Ltd.
Sai Life Sciences Ltd. operates in the pharmaceutical industry, focusing on providing contract research, development, and manufacturing services. The company is based in Hyderabad, India, and serves a global clientele with its comprehensive solutions in drug discovery and development.
Average Trading Volume: 373,266
See more insights into SAILIFE stock on TipRanks’ Stock Analysis page.